Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Parasitol Res ; 115(10): 3951-61, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27344453

RESUMEN

Several signaling molecules that govern development in higher animals have been identified in the parasite Schistosoma mansoni, including the transforming growth factor ß, protein tyrosine kinases, nuclear hormone receptors, among others. The Notch pathway is a highly conserved signaling mechanism which is involved in a wide variety of developmental processes including embryogenesis and oogenesis in worms and flies. Here we aimed to provide the molecular reconstitution of the Notch pathway in S. mansoni using the available transcriptome and genome databases. Our results also revealed the presence of the transcripts coded for SmNotch, SmSu(H), SmHes, and the gamma-secretase complex (SmNicastrin, SmAph-1, and SmPen-2), throughout all the life stages analyzed. Besides, it was observed that the viability and separation of adult worm pairs were not affected by treatment with N-[N(3,5)-difluorophenacetyl)-L-Alanyl]-S-phenylglycine t-butyl ester (DAPT), a Notch pathway inhibitor. Moreover, DAPT treatment decreased the production of phenotypically normal eggs and arrested their development in culture. Our results also showed a significant decrease in SmHes transcript levels in both adult worms and eggs treated with DAPT. These results provide, for the first time, functional validation of the Notch pathway in S. mansoni and suggest its involvement in parasite oogenesis and embryogenesis. Given the complexity of the Notch pathway, further experiments shall highlight the full repertoire of Notch-mediated cellular processes throughout the S. mansoni life cycle.


Asunto(s)
Genoma de los Helmintos/genética , Receptores Notch/genética , Schistosoma mansoni/genética , Esquistosomiasis mansoni/parasitología , Transducción de Señal , Transcriptoma , Secretasas de la Proteína Precursora del Amiloide/antagonistas & inhibidores , Secretasas de la Proteína Precursora del Amiloide/genética , Animales , Biología Computacional , Diaminas/farmacología , Femenino , Proteínas del Helminto/genética , Proteínas del Helminto/metabolismo , Humanos , Estadios del Ciclo de Vida/efectos de los fármacos , Masculino , Ratones Endogámicos BALB C , Óvulo/efectos de los fármacos , Receptores Notch/metabolismo , Schistosoma mansoni/efectos de los fármacos , Schistosoma mansoni/fisiología , Caracoles , Tiazoles/farmacología
2.
Biodegradation ; 25(5): 719-33, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24929339

RESUMEN

Among the greatest challenges to the full implementation of biological sulfate reduction are the cost and availability of the electron source. With the development of the biofuel industry, new organic substrates have become available. Therefore, this work sought to compare the performance of a sulfidogenic process utilizing either lactate or glycerol as the substrate for sulfate-reducing bacteria (SRB) growth. Although sulfate reduction is energetically more favorable with lactate, glycerol is a less expensive alternative because excess production is forecasted with the worldwide development of the biodiesel industry. Continuous experiments were performed in a fluidized bed (FB) reactor containing activated carbon as a carrier for a mixed bacterial population composed of sulfate-reducing and fermentative bacteria. During the lactate-fed phases, incomplete oxidation of lactate to acetate by SRB was the dominant metabolic pathway resulting in as much as 90 % sulfate reduction and high acetate concentrations (2.7 g L(-1)). Conversely, in the glycerol-fed phases, glycerol degradation resulted from syntrophic cooperation between sulfate-reducing and fermentative bacteria that produce butyrate along with acetate (1.0 g L(-1)) as oxidation products. To our knowledge, this is the first report of butyrate formation during sulfate reduction in a glycerol-fed continuous-flow reactor. Sulfate concentrations were reduced by about 90 % (from 2,000 to 100-300 mg L(-1)) when glycerol was being fed to the reactor. Since the FB reactor was able to stand a change from lactate to glycerol, this reactor is recommended as the preferred option should glycerol be selected as a cost-effective alternative to lactate for continuous sulfate reduction.


Asunto(s)
Reactores Biológicos/microbiología , Glicerol/metabolismo , Ácido Láctico/metabolismo , Sulfatos/metabolismo
3.
Parasitol Int ; 58(1): 61-8, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19007911

RESUMEN

RNA silencing refers to a series of nuclear and cytoplasmatic processes involved in the post-transcriptional regulation of gene expression or post-transcriptional gene silencing (PTGS), either by sequence-specific mRNA degradation or by translational arrest. The best characterized small RNAs are microRNAs (miRNAs), which predominantly perform gene silencing through post-transcriptional mechanisms. In this work we used bioinformatic approaches to identify the parasitic trematode Schistosoma mansoni sequences that are similar to enzymes involved in the post-transcriptional gene silencing mediated by miRNA pathway. We used amino acid sequences of well-known proteins involved in the miRNA pathway against S. mansoni genome and transcriptome databases identifying a total of 13 putative proteins in the parasite. In addition, the transcript levels of SmDicer1 and SmAgo2/3/4 were identified by qRT-PCR using cercariae, adult worms, eggs and in vitro cultivated schistosomula. Our results showed that the SmDicer1 and SmAgo2/3/4 are differentially expressed during schistosomula development, suggesting that the miRNA pathway is regulated at the transcript level and therefore may control gene expression during the life cycle of S. mansoni.


Asunto(s)
Biología Computacional/métodos , Regulación de la Expresión Génica , Proteínas del Helminto , MicroARNs/metabolismo , Interferencia de ARN , Schistosoma mansoni/crecimiento & desarrollo , Schistosoma mansoni/metabolismo , Secuencia de Aminoácidos , Animales , Genes de Helminto , Proteínas del Helminto/química , Proteínas del Helminto/genética , Proteínas del Helminto/metabolismo , Estadios del Ciclo de Vida , Ratones , Ratones Endogámicos BALB C , MicroARNs/química , MicroARNs/genética , Datos de Secuencia Molecular , Filogenia , Proteínas de Unión al ARN/química , Proteínas de Unión al ARN/genética , Proteínas de Unión al ARN/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Ribonucleasa III/química , Ribonucleasa III/genética , Ribonucleasa III/metabolismo , Schistosoma mansoni/genética , Alineación de Secuencia
4.
Nat Genet ; 35(2): 148-57, 2003 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12973350

RESUMEN

Schistosoma mansoni is the primary causative agent of schistosomiasis, which affects 200 million individuals in 74 countries. We generated 163,000 expressed-sequence tags (ESTs) from normalized cDNA libraries from six selected developmental stages of the parasite, resulting in 31,000 assembled sequences and 92% sampling of an estimated 14,000 gene complement. By analyzing automated Gene Ontology assignments, we provide a detailed view of important S. mansoni biological systems, including characterization of metazoa-specific and eukarya-conserved genes. Phylogenetic analysis suggests an early divergence from other metazoa. The data set provides insights into the molecular mechanisms of tissue organization, development, signaling, sexual dimorphism, host interactions and immune evasion and identifies novel proteins to be investigated as vaccine candidates and potential drug targets.


Asunto(s)
Schistosoma mansoni/genética , Transcripción Genética , Animales , Mapeo Cromosómico , Etiquetas de Secuencia Expresada , Genes de Helminto , Proteínas del Helminto/genética , Humanos , Datos de Secuencia Molecular , Schistosoma mansoni/patogenicidad , Schistosoma mansoni/fisiología , Esquistosomiasis mansoni/parasitología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA